Patent · US Expired

Orodispersible tablets containing fexofenadine

US6723348B2 · kind B2 · utility

60Cited by
3References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 2001
Grant dateApr 20, 2004
Priority date
Expiry dateNov 26, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/1611
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention concerns orodispersible tablets, which are able to disintegrate in the buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, preferably in less than 40 seconds, containing fexofenadine in the form of coated granules, and a mixture of excipients comprising at least one disintegrating agent, a soluble diluent agent, a lubricant and optionally a swelling agent, a permeabilizing agent, sweeteners, flavoring agents and colors; the process for obtaining such orodispersible tablets and the coated granules incorporated therein and the use of said orodispersible tablets in the treatment of seasonal allergic rhinitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.